Protagenic Therapeutics, Inc.\new (PTIX) Revenue 2017–2026
Protagenic Therapeutics, Inc.\new (PTIX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2026 · since FY2017: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $0 | — |
| FY2025 | $0 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTIX financial trends
PTIX Net incomePTIX Net marginPTIX Gross profitPTIX Gross marginPTIX Operating incomePTIX Operating marginPTIX Operating cash flowPTIX Free cash flowPTIX Capital expendituresPTIX Return on equityPTIX Stock buybacksPTIX Dividends paidPTIX Total assetsPTIX Total liabilitiesPTIX Shareholders’ equityPTIX overview →